Biology subjects

Le, T. D.

Publications and source records attributed to Le, T. D..

11 recordsLinked to original sources

bioRxiv2025

SH2scan: Mapping SH2 domain-ligand binding selectivity for inhibitors and degraders

Drug discovery targeting SH2 domains (key protein-protein interaction modules) has been hampered by a lack of assay systems evaluating synthetic ligand binding selectivity toward SH2 domains, to reduce potential off-target effects. In addition, the molecular determinants for synthetic ligand engagement to SH2 domains across the target class have yet to be defined. Here, we developed SH2scan, a high-throughput competition binding assay platform to quantify ligand-SH2 domain interactions, covering >80% of the target class. We uncovered unique binding selectivity profiles and quantified a broad range of dissociation constants (KDs) for 9 synthetic ligands of SH2 domains from the scientific literature with a range of reported primary targets. These results demonstrate that SH2scan can be used to design more selective compounds targeting SH2 domains. The platform can be further leveraged for the discovery of new molecular probes for the dissection of cellular protein-protein interaction networks.

pharmacology and toxicology↗

bioRxiv2023

Scanning sample-specific miRNA regulation from bulk and single-cell RNA-sequencing data

RNA-sequencing technology provides an effective tool for understanding miRNA regulation in complex human diseases, including cancers. A large number of computational methods have been developed to make use of bulk and single-cell RNA-sequencing data to identify miRNA regulations at the resolution of multiple samples (i.e. group of cells or tissues). However, due to the heterogeneity of individual samples, there is a strong need to infer miRNA regulation specific to individual samples to uncover miRNA regulation at single-sample resolution level. Here, we develop a framework, Scan, for scanning sample-specific miRNA regulation. Since a single network inference method or strategy cannot perform well for all types of new data, Scan incorporates 27 network inference methods and two strategies to infer tissue-specific or cell-specific miRNA regulation from bulk or single-cell RNA-sequencing data. Results on bulk and single-cell RNA-sequencing data demonstrate the effectiveness of Scan in inferring sample-specific miRNA regulation. Moreover, we have found that incorporating priori information of miRNA targets can improve the accuracy of miRNA target prediction. In addition, Scan can contribute to the clustering cells/tissues and construction of cell/tissue correlation networks. Finally, the comparison results have shown that the performance of network inference methods is likely to be data-specific, and selecting optimal network inference methods is required for more accurate prediction of miRNA targets. We have made Scan freely available to the public to help infer sample-specific miRNA regulation for new data, benchmark new network inference methods and deepen the understanding of miRNA regulation at the resolution of individual samples.

bioinformatics↗

bioRxiv2023

Pan-cancer characterization of ncRNA synergistic competition uncovers potential carcinogenic biomarkers

Non-coding RNAs (ncRNAs) act as important modulators of gene expression and they have been confirmed to play critical roles in the physiology and development of malignant tumors. Understanding the synergism of multiple ncRNAs in competing endogenous RNA (ceRNA) regulation can provide important insights into the mechanisms of malignant tumors caused by ncRNA regulation. In this work, we present a framework, SCOM, for identifying ncRNA synergistic competition. We systematically construct the landscape of ncRNA synergistic competition across 31 malignant tumors, and reveal that malignant tumors tend to share hub ncRNAs rather than the ncRNA interactions involved in the synergistic competition. In addition, the synergistic competition ncRNAs (i.e. ncRNAs involved in the synergistic competition) are likely to be involved in drug resistance, contribute to distinguishing molecular subtypes of malignant tumors, and participate in immune regulation. Furthermore, SCOM can help to infer ncRNA synergistic competition across malignant tumors and uncover potential diagnostic and prognostic biomarkers of malignant tumors. Altogether, the SCOM framework and the resulting web-based database SCOMdb (www.comblab.cn/SCOMdb/) serve as a useful resource for exploring ncRNA regulation and to accelerate the identification of carcinogenic biomarkers. Author summaryAbundant evidence reveals that ncRNAs are important modulators of gene expression, and it is important for us to understand the regulation of ncRNAs in malignant tumors. In this work, we hypothesize that ncRNAs acting as ceRNAs can crosstalk with each other in the form of synergistic competition. We name the hypothesis as the ncRNA synergistic competition hypothesis. To uncover potential carcinogenic biomarkers, we present a framework, SCOM, for identifying ncRNA synergistic competition in malignant tumors. From the perspective of synergistic competition, we have shown that the synergistic competition ncRNAs are likely to involve in drug resistance, contribute to distinguishing molecular subtypes of malignant tumors, and participate in immune regulation. In addition, the synergistic competition ncRNAs are potential diagnostic and prognostic biomarkers of malignant tumors. We believe that the proposed framework SCOM and the web-based database SCOMdb can contribute to the design of reliable diagnosis and treatment biomarkers for malignant tumors.

bioinformatics↗

bioRxiv2021

Stable breast cancer prognosis

Predicting breast cancer prognosis helps improve the treatment and management of the disease. In the last decades, many prediction models have been developed for breast cancer prognosis based on transcriptomic data. A common assumption made by these models is that the test and training data follow the same distribution. However, in practice, due to the heterogeneity of breast cancer and the different environments (e.g. hospitals) where data are collected, the distribution of the test data may shift from that of the training data. For example, new patients likely have different breast cancer stage distribution from those in the training dataset. Thus these existing methods may not provide stable prediction performance for breast cancer prognosis in situations with the shift of data distribution. In this paper, we present a novel stable prediction method for reliable breast cancer prognosis under data distribution shift. Our model, known as Deep Global Balancing Cox regression (DGBCox), is based on the causal inference theory. In DGBCox, firstly high-dimensional gene expression data is transferred to latent network-based representations by a deep auto-encoder neural network. Then after balancing the latent representations using a proposed causality-based approach, causal latent features are selected for breast cancer prognosis. Causal features have persistent relationships with survival outcomes even under distribution shift across different environments according to the causal inference theory. Therefore, the proposed DGBCox method is robust and stable for breast cancer prognosis. We apply DGBCox to 12 test datasets from different breast cancer studies. The results show that DGBCox outperforms benchmark methods in terms of both prediction accuracy and stability. We also propose a permutation importance algorithm to rank the genes in the DGBCox model. The top 50 ranked genes suggest that the cell cycle and the organelle organisation could be the most relevant biological processes for stable breast cancer prognosis. Author summaryVarious prediction models have been proposed for breast cancer prognosis. The prediction models usually train on a dataset and predict the survival outcomes of patients in new test datasets. The majority of these models share a common assumption that the test and training data follow the same distribution. However, as breast cancer is a heterogeneous disease, the assumption may be violated in practice. In this study, we propose a novel method for reliable breast cancer prognosis when the test data distribution shifts from that of the training data. The proposed model has been trained on one dataset and applied to twelve test datasets from different breast cancer studies. In comparison with the benchmark methods in breast cancer prognosis, our model shows better prediction accuracy and stability. The top 50 important genes in our model provide clues to the relationship between several biological mechanisms and clinical outcomes of breast cancer. Our proposed method in breast cancer can potentially be adapted to apply to other cancer types.

bioinformatics↗

bioRxiv2020

Exploring cell-specific miRNA regulation with single-cell miRNA-mRNA co-sequencing data

BackgroundExisting computational methods for studying miRNA regulation are mostly based on bulk miRNA and mRNA expression data. However, bulk data only allows the analysis of miRNA regulation regarding a group of cells, rather than the miRNA regulation unique to individual cells. Recent advance in single-cell miRNA-mRNA co-sequencing technology has opened a way for investigating miRNA regulation at single-cell level. However, as currently single-cell miRNA-mRNA co-sequencing data is just emerging and only available at small-scale, there is a strong need of novel methods to exploit existing single-cell data for the study of cell-specific miRNA regulation. ResultsIn this work, we propose a new method, CSmiR (Cell-Specific miRNA regulation) to use single-cell miRNA-mRNA co-sequencing data to identify miRNA regulatory networks at the resolution of individual cells. We apply CSmiR to the miRNA-mRNA co-sequencing data in 19 K562 single-cells to identify cell-specific miRNA-mRNA regulatory networks for understanding miRNA regulation in each K562 single-cell. By analyzing the obtained cell-specific miRNA-mRNA regulatory networks, we observe that the miRNA regulation in each K562 single-cell is unique. Moreover, we conduct detailed analysis on the cell-specific miRNA regulation associated with the miR-17/92 family as a case study. Finally, through exploring cell-cell similarity matrix characterized by cell-specific miRNA regulation, CSmiR provides a novel strategy for clustering single-cells to help understand cell-cell crosstalk. ConclusionsTo the best of our knowledge, CSmiR is the first method to explore miRNA regulation at a single-cell resolution level, and we believe that it can be a useful method to enhance the understanding of cell-specific miRNA regulation.

bioinformatics↗

bioRxiv2019

Predicting cellular position in the Drosophila embryo from Single-Cell Transcriptomics data

Single-cell RNA-seq technologies are rapidly evolving but while very informative, in standard scRNAseq experiments the spatial organization of the cells in the tissue of origin is lost. Conversely, spatial RNA-seq technologies designed to keep the localization of the cells have limited throughput and gene coverage. Mapping scRNAseq to genes with spatial information increases coverage while providing spatial location. However, methods to perform such mapping have not yet been benchmarked. To bridge the gap, we organized the DREAM Single-Cell Transcriptomics challenge focused on the spatial reconstruction of cells from the Drosophila embryo from scRNAseq data, leveraging as gold standard genes with in situ hybridization data from the Berkeley Drosophila Transcription Network Project reference atlas. The 34 participating teams used diverse algorithms for gene selection and location prediction, while being able to correctly localize rare subpopulations of cells. Selection of predictor genes was essential for this task and such genes showed a relatively high expression entropy, high spatial clustering and the presence of prominent developmental genes such as gap and pair-ruled genes and tissue defining markers.

systems biology↗

bioRxiv2019

Identifying miRNA synergism using multiple-intervention causal inference

BackgroundStudying multiple microRNAs (miRNAs) synergism in gene regulation could help to understand the regulatory mechanisms of complicated human diseases caused by miRNAs. Several existing methods have been presented to infer miRNA synergism. Most of the current methods assume that miRNAs with shared targets at the sequence level are working synergistically. However, it is unclear if miRNAs with shared targets are working in concert to regulate the targets or they individually regulate the targets at different time points or different biological processes. A standard method to test the synergistic activities is to knock-down multiple miRNAs at the same time and measure the changes in the target genes. However, this approach may not be practical as we would have too many sets of miRNAs to test.\n\nResultsIn this paper, we present a novel framework called miRsyn for inferring miRNA synergism by using a causal inference method that mimics the multiple-intervention experiments, e.g. knocking-down multiple miRNAs, with observational data. Our results show that several miRNA-miRNA pairs that have shared targets at the sequence level are not working synergistically at the expression level. Moreover, the identified miRNA synergistic network is small-world and biologically meaningful, and a number of miRNA synergistic modules are significantly enriched in breast cancer. Our further analyses also reveal that most of synergistic miRNA-miRNA pairs show the same expression patterns. The comparison results indicate that the proposed multiple-intervention causal inference method performs better than the single-intervention causal inference method in identifying miRNA synergistic network.\n\nConclusionsTaken together, the results imply that miRsyn is a promising framework for identifying miRNA synergism, and it could enhance the understanding of miRNA synergism in breast cancer.

bioinformatics↗

bioRxiv2019

Personalized Annotation-based Networks (PAN) for the Prediction of Breast Cancer Relapse

The classification of clinical samples based on gene expression data is an important part of precision medicine. However, it has proved difficult to accurately predict survival outcomes and treatment responses for cancer patients. In this manuscript, we show how transforming gene expression data into a set of personalized (sample-specific) networks can allow us to harness existing graph-based methods to improve classifier performance. Existing approaches to personalized gene networks all have the limitation that they depend on other samples in the data and must get re-computed whenever a new sample is introduced. Here, we propose a novel method, called Personalized Annotation-based Networks (PAN), that avoids this limitation by using curated annotation databases to transform gene expression data into a graph. These databases organize genes into overlapping gene sets, called annotations, that we use to build a network where nodes represent functional terms and edges represent the similarity between them. Unlike competing methods, PANs are calculated for each sample independent of the population, making it a more efficient way to obtain single-sample networks. Using three breast cancer datasets as a case study (METABRIC and a super-set of GEO studies), we show that PAN classifiers not only predict cancer relapse better than gene features alone, but also outperform PPI and population-level graph-based classifiers. This work demonstrates the practical advantages of graph-based classification for high-dimensional genomic data, while offering a new approach to making sample-specific networks. Supplementary informationThe codes and data are available at https://github.com/thinng/PAN. ContactThuc.Le@unisa.edu.au

bioinformatics↗

bioRxiv2018

miRsponge: an R/Bioconductor package for the identification and analysis of miRNA sponge interaction networks and modules

BackgroundA microRNA (miRNA) sponge is an RNA molecule with multiple tandem miRNA response elements that can sequester miRNAs from their target mRNAs. Despite growing appreciation of the importance of miRNA sponges, our knowledge of their complex functions remains limited. Moreover, there is still a lack of miRNA sponge research tools that help researchers to quickly compare their proposed methods with other methods, apply existing methods to new datasets, or select appropriate methods for assisting in subsequent experimental design.\n\nResultsTo fill the gap, we present an R/Bioconductor package, miRsponge, for simplifying the procedure of identifying and analyzing miRNA sponge interaction networks and modules. It provides seven popular methods and an integrative method to identify miRNA sponge interactions. Moreover, it supports the validation of miRNA sponge interactions and the identification of miRNA sponge modules, as well as functional enrichment and survival analysis of miRNA sponge modules.\n\nConclusionsThis package enables researchers to quickly evaluate their new methods, apply existing methods to new datasets, and consequently speed up miRNA sponge research.

bioinformatics↗

bioRxiv2018

miRBaseConverter: An R/Bioconductor Package for Converting and Retrieving miRNA Name, Accession, Sequence and Family Information in Different Versions of miRBase

BackgroundmiRBase is the primary repository for published miRNA sequence and annotation data, and serves as the \"go-to\" place for miRNA research. However, the definition and annotation of miRNAs have been changed significantly across different versions of miRBase. The changes cause inconsistency in miRNA related data between different databases and articles published at different times. Several tools have been developed for different purposes of querying and converting the information of miRNAs between different miRBase versions, but none of them individually can provide the comprehensive information about miRNAs in miRBase and users will need to use a number of different tools in their analyses.\n\nResultsWe introduce miRBaseConverter, an R package integrating the latest miRBase version 22 available in Bioconductor to provide a suite of functions for converting and retrieving miRNA name (ID), accession, sequence, species, version and family information in different versions of miRBase. The package is implemented in R and available under the GPL-2 license from the Bioconductor website (http://bioconductor.org/packages/miRBaseConverter/). A Shiny-based GUI suitable for non-R users is also available as a standalone application from the package and also as a web application at http://nugget.unisa.edu.au:3838/miRBaseConverter. miRBaseConverter has a built-in database for querying miRNA information in all species and for both pre-mature and mature miRNAs defined by miRBase. In addition, it is the first tool for batch querying the miRNA family information. The package aims to provide a comprehensive and easy-to-use tool for miRNA research community where researchers often utilize published miRNA data from different sources.\n\nConclusionsThe Bioconductor package miRBaseConverter and the Shiny-based web application are presented to provide a suite of functions for converting and retrieving miRNA name, accession, sequence, species, version and family information in different versions of miRBase. The package will serve a wide range of applications in miRNA research and could provide a full view of the miRNAs of interest.

genomics↗

bioRxiv2018

Identifying miRNA-mRNA regulatory relationships in breast cancer with invariant causal prediction

microRNAs (miRNAs) regulate gene expression at the post-transcriptional level and they play an important role in various biological processes in the human body. Therefore, identifying their regulation mechanisms is essential for the diagnostics and therapeutics for a wide range of diseases. There have been a large number of researches which use gene expression profiles to resolve this problem. However, the current methods have their own limitations. Some of them only identify the correlation of miRNA and mRNA expression levels instead of the causal or regulatory relationships while others infer the causality but with a high computational complexity. To overcome these issues, in this study, we propose a method to identify miRNA-mRNA regulatory relationships in breast cancer using the invariant causal prediction. The key idea of invariant causal prediction is that the cause miRNAs of their target mRNAs are the ones which have persistent causal relationships with the target mRNAs across different environments. In this research, we aim to find miRNA targets which are consistent across different breast cancer subtypes. Thus, first of all, we apply the Pam50 method to categorise BRCA samples into different environment\" groups based on different cancer subtypes. Then we use the invariant causal prediction method to find miRNA-mRNA regulatory relationships across subtypes. We validate the results with the miRNA-transfected experimental data and the results show that our method outperforms the state-of-the-art methods. In addition, we also integrate this new method with the Pearson correlation analysis method and Lasso in an ensemble method to take the advantages of these methods. We then validate the results of the ensemble method with the experimentally confirmed data and the ensemble method shows the best performance, even comparing to the proposed causal method. Functional enrichment analyses show that miRNAs in the regulatory relationship predicated by the proposed causal method tend to synergistically regulate target genes, indicating the usefulness of these methods, and the identified miRNA targets could be used in the design of wet-lab experiments to discover the causes of breast cancer.\n\nAuthor summaryCancer is a disease of cells in human body and it causes a high rate of deaths world wide. There has been evidence that non-coding RNAs are key players in the development and progression of cancer. Among the different types of non-coding RNAs, miRNAs, which are short non-coding RNAs, regulate gene expression and play an important role in different biological processes as well as various cancer types. To design better diagnostic and therapeutic plans for cancer patients, we need to know the roles of miRNAs in cancer initialisation and development, and their regulation mechanisms in the human body. In this study, we propose algorithms to identify miRNA-mRNA regulatory relationships in breast cancer. Comparing our methods with existing methods in predicting miRNA targets, our methods show a better performance. The estimated miRNA targets from our methods could be a potential source for further wet-lab experiments to discover the causes of breast cancer.

bioinformatics↗